Evidence behind the results
The source tables below make the headline results and nominated compounds inspectable. Download the rows, compare the populations, and follow the provenance manifest to the source analysis. Tables retain compound identifiers and measured results; structure images and SMILES/scaffold fields are withheld. Download hashes refer to the sanitized files; original source hashes are labeled separately.
Source release. The full pilot dataset is on Hugging Face (Zafrens/zscreen-pilot) with per-file SHA-256 manifests; an interactive Functional Drug Atlas covers a portion of it.
How to read the headline numbers
Scale
162,914 compounds and 190,699 compound–context profiles describe the pilot dataset analyzed in the white paper, not the platform’s capacity.
Learnability
On 7,544 HEK293 compounds whose building blocks were withheld from training, the additive recipe model reaches program r = 0.363 and 2.62× selection enrichment versus 0.337 and 2.53× for an end-to-end graph network trained on the same profiles. Retrospective replays recover the same responses with 33–52% fewer measurements.
Discovery
2,626 series–target matches occupy 178 clusters; 2,229 pass the lineage-support gate, which participates in selection. Chemical discovery gives 110 matches across 51 context–series labels; 33 have both internal-control and CRISPR support, including all ten highest-ranked chemical-twin series.
Calibration
CIGS 0.822 is a median matched-panel rank for 17 qualified controls. MZ1 AUROC 0.799 is chromatin-class recovery in H1650. CRISPR 0.580 is a compound median across 25 matched Tier-1 controls.
Controls that change how a claim should be read
Source tables
| Dataset | What it supports |
|---|---|
| platform_counts.json | Pilot-dataset scale |
| fold0_reference_model_summary.csv | Exact per-context simple and transformer results |
| cold_start_metrics.csv | Unseen-building-block head-to-head on 7,544 HEK293 compounds |
| replay_savings.csv | Retrospective measurement savings |
| activeseq_treatment_results.txt | ActiveSeq treatment-recognition and population-pooling results |
| cigs_qualified.csv | CIGS qualified-control denominator and panel metrics |
| cigs_calibration.csv | Full-atlas and salt-aware calibration metrics |
| chemical_leads.csv | The ten highest-ranked chemical-twin series and replication counts |
| chemical_qualified.csv | 110 chemical matches reproduced by the source gate |
| crispr_calibration.csv | Compound-level and evaluation-row CRISPR calibration |
| genetic_leads.csv | The ten highest-ranked genetic-twin series and their selection fields |
| genetic_members.csv | Measured active/inactive analogs, wells and devices |
| provenance.json | Source paths and SHA-256 hashes for every released table |
Next experiments
Prioritize fresh dose–response measurements and direct target assays for active/inactive compound pairs. Recheck single-well chemical series (ZS-SAR-01, -03, -06, -07) first.
